Adial Pharmaceuticals, Inc.

NASDAQ (USD): Adial Pharmaceuticals, Inc. (ADIL)

Last Price

0.79

Today's Change

+0.01 (1.28%)

Day's Change

0.765 - 0.79

Trading Volume

29,741

Overview

Market Cap

5 Million

Shares Outstanding

6 Million

Avg Volume

187,333

Avg Price (50 Days)

1.03

Avg Price (200 Days)

1.14

PE Ratio

-0.29

EPS

-2.77

Earnings Announcement

31-Mar-2025

Previous Close

0.78

Open

0.77

Day's Range

0.765 - 0.7899

Year Range

0.72 - 4.17

Trading Volume

30,266

Price Change Highlight

1 Day Change

1.28%

5 Day Change

-2.48%

1 Month Change

-27.53%

3 Month Change

-21.79%

6 Month Change

-16.90%

Ytd Change

-25.48%

1 Year Change

-26.18%

3 Year Change

-98.66%

5 Year Change

-98.14%

10 Year Change

-99.22%

Max Change

-99.22%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment